The QualityStocks Daily Thursday, July 5th, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (ANW) +222.22%

QualityStocks (CTBO) +82.17%

PennyStockProphet (DFBG) +57.28%

The QualityStocks Daily Stock List

Galaxy Gaming, Inc. (GLXZ)

TaglichBrothers, The Green Baron, FeedBlitz, Red Chip, SmallCapVoice, Marketbeat, and Stock Profile reported earlier on Galaxy Gaming, Inc. (GLXZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.  

Galaxy Gaming, Inc. is the world's largest independent developer, manufacturer, and distributor of casino table games and enhanced systems. The Company develops, manufactures, and distributes unique proprietary table games, state-of-the-art electronic wagering platforms, and enhanced bonusing systems to land-based, riverboat, cruise ships, and online casinos around the world. Galaxy Gaming has its corporate headquarters in Las Vegas, Nevada.

Galaxy Gaming has an installed base of its products on thousands of gaming tables located in hundreds of casinos. The Company sells its products chiefly through its internal sales force, to casinos throughout North America, the Caribbean, the British Isles, Europe, and Africa. Moreover, Galaxy Gaming sells its products to cruise ships and internet gaming sites globally.    

The Company is the exclusive provider of SpectrumVision. This is a proprietary technology used to detect invisible markings on playing cards.

Additionally, Galaxy Gaming is expanding its international footprint by way of its partnership with WPT Enterprises, Inc.  WPT Enterprises is the owner of the World Poker Tour. 

Furthermore, through its iGaming partner, Progressive Games Marketing Ltd., Galaxy Gaming licenses its proprietary table games to the online gaming industry. The Company’s games can be played online at FeelTheRush.com.

In May, Galaxy Gaming announced its results for the quarter ended March 31, 2018. For Q1 2018 in comparison to Q1 2017, the Company’s Revenue increased 25 percent to $4,361K. Revenue increased 20 percent to $4,154K, excluding the effect of accounting change.

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased 28 percent to $1,559K. Pre-tax income grew 184 percent to $682K, and Net Income grew 231 percent to $537K.

Recently, Galaxy Gaming announced the acquisition of a portfolio of intellectual property (IP) developed by students participating in UNLV’s Center for Gaming Innovation. This portfolio comprises an array of table games and table-game apparatus that was further prepared for commercialization and sold to Galaxy Gaming by Big Bet Gaming, LLC.

Mr. Mark L. Yoseloff, Ph.D., Executive Director of the Center of Gaming Innovation at UNLV, leads a semester-long course connecting students with established gaming leaders who serve as guest lecturers and mentors. The classes concentrate on gaming commercialization concepts and technology, the patent process, marketing, and successful business strategies.

Galaxy Gaming, Inc. (GLXZ), closed Thursday's trading session at $1.21, up 6.14%, on 100 volume with 1 trade. The average volume for the last 60 days is 19,745 and the stock's 52-week low/high is $0.51/$1.47.

chart

Progressive Care, Inc. (RXMD)

Penny Stock Tweets, Street Register, Wall Street Analyzer, Zacks, First Look Equities, Business Insider, Wallet Investor, SmarterAnalyst, InvestorsHub, ClayTrader, Stockhouse, OTC Markets, SeeThruEquity, TradingView, OTC.Watch, 4-Traders, Insider Financial, and Investors Hangout reported on Progressive Care, Inc. (RXMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Progressive Care, Inc., through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization. It is moving forward in its work to grow the Company by expanding its facility, adding new locations, acquiring operating pharmacies, and further developing its present business lines. Progressive Care is headquartered in North Miami Beach, Florida.

The Company owns PharmCo LLC. PharmCo was formed in 2005 as a Florida Limited Liability Corporation with the aim of becoming a first-rate pharmacy in the South Florida community. PharmCo has developed into a health services enterprise, which centers on the provision of prescription pharmaceuticals.

PharmCo’s compounding department specializes in formularies. These include non-narcotic topical pain creams, wound care creams, scar gels, and hormone replacement therapies. Also, PharmCo offers EnovaRx, which are Food and Drug Administration (FDA) approved manufactured pain creams. These are readily available with a prescription.

Additionally, PharmCo prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules. These are 100 percent Kosher and Halal certified.

In essence, Progressive Care is a provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. Furthermore, the Company is a provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

Progressive Care opened Smart Medical Alliance, Inc. on September 1, 2016. It opened Smart Medical to assist healthcare providers with navigating the complex risk management environment of their insurance network contracts. Smart Medical Alliance provides management and support services to doctors and administrators under capitated and fee-for-services insurance contracts.

Progressive Care announced this past March that it executed a Letter of Intent (LOI) to purchase a pharmacy in Palm Beach County. The Company signed an LOI on March 1, 2018 to purchase a pharmacy in Palm Beach County for $300,000. This acquisition target is close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, as well as commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.

This week, Progressive Care announced that it completed the acquisition of a Touchpoint pharmacy in Palm Beach County. This second location will enable Progressive Care’s growth by expanding the delivery radius of the Company’s pharmacy operations to now include Miami-Dade, Broward, Palm Beach and Martin County. In addition, it will reduce costs of expansion of products and services and increase prescription dispensing efficiency.

Progressive Care has added to its increasing fleet of robotic pharmacy equipment. This is with the completion of installation of a TCGRx Automated Pouch Packaging System at the Company’s Miami-Dade County PharmCo location.

Progressive Care has also started developing its own proprietary tele-pharmacy software. This is to digitally communicate with patients, physicians, pharmacists, and caretakers worldwide and expand its kiosk program.

Progressive Care, Inc. (RXMD), closed Thursday's trading session at $0.0597, down 15.80%, on 2,559,411 volume with 135 trades. The average volume for the last 60 days is 3,355,362 and the stock's 52-week low/high is $0.01/$0.2659.

chart

Auxly Cannabis Group, Inc. (CBWTF)

MicroSmallCap, Zacks, All Penny Stocks, OTC Markets, Investor Place, MarketWatch, Daily Marijuana Observer, InvestorsHub, Stockhouse, Marijuana Stox, TradingView, Wallmine, 4-Traders, The National Marijuana News, Marketbeat, The Street, Marijuana Index, and Pot Network reported on Auxly Cannabis Group, Inc. (CBWTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Auxly Cannabis Group, Inc. operates as a cannabis streaming company. Its mandate is to facilitate growth for its partners through providing them with financial support and sharing the Company’s collective industry experience. Auxly Cannabis invests and supports a broad array of cannabis cultivation companies.

Auxly Cannabis is headquartered in Vancouver, British Columbia. The Company previously went by the name Cannabis Wheaton Income Corp. It changed its name to Auxly Cannabis Group, Inc. last month.

The Company has created a foundational platform covering the whole cannabis value-chain, minimizing risk while at the same time maximizing exposure to multiple, geographically-diverse cannabis companies via a single source.

Auxly Cannabis’ team has a wealth of knowledge from cultivation, regulatory, construction, retail, branding, finance and technology. The Company is using the stream, or streaming model, to finance cannabis companies.

Auxly Cannabis’ provides financial support for cannabis facility expansions, operations, and initial construction. It does so in exchange for minority equity interests and a portion of the cultivation production. Auxly Cannabis partners maintain their brand autonomy. In addition, they obtain access to better scaling flexibility. 

In November 2017, Auxly Cannabis announced the closing of the acquisition of all the issued and outstanding shares of RockGarden Medicinals (2014), Inc. pursuant to the terms of a definitive share purchase agreement dated October 31, 2017. RockGarden was granted a cultivation license on August 25, 2017.  RockGarden is a privately owned licensed producer of cannabis pursuant to the ACMPR.

This past February, Auxly Cannabis announced that it entered into a joint venture (JV) with Mr. Peter Quiring, one of Canada’s largest greenhouse builders and operators, by way of a newly formed subsidiary (GreenhouseCo), to develop, build and operate a state-of-the-art purpose-built greenhouse for cannabis cultivation in Leamington, Ontario.  Mr. Quiring will act as Chief Executive Officer of GreenhouseCo.

Pursuant to the agreement, Mr. Quiring, through South Essex Fabricating, will be responsible for the design, construction and operation of the Facility.  The Company will be responsible for funding the project and assisting JVCo in obtaining its ACMPR license for the cultivation and sale of cannabis through providing JVCo with all the resources and expertise necessary to attain the License.

Auxly Cannabis Group, Inc. (CBWTF), closed Thursday's trading session at $0.863, down 3.03%, on 1,511,389 volume with 1,008 trades. The average volume for the last 60 days is 1,279,471 and the stock's 52-week low/high is $0.5213/$2.70.

chart

Liquidmetal® Technologies, Inc. (LQMT)

Greenbackers, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, PennyStocks Forever, and Penny Stocks VIP reported previously on Liquidmetal Technologies, Inc. (LQMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the foremost developer of bulk alloys, which use the performance advantages that amorphous alloy technology provides. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in comparison to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies  has its corporate office in Rancho Santa Margarita, California, where the Company also has its Manufacturing Center of Excellence.

Liquidmetal® Technologies is the first company to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a wide assortment of industries.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing like plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in many cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys. 

The Company’s "bulk" amorphous alloys possess advantages normally associated with plastics. These include the ability to undergo molding into precision, complex, and highly finished products. The Company controls the Intellectual Property (IP) rights with greater than 70 U.S. patents.     

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications.

For Fiscal Year (FY) 2017, Liquidmetal® Technologies generated $321,000 in Revenue as it continued to concentrate on the development and manufacturing of prototype and commercial parts for its customers and partnering with licensees on the development of its technology and production processes.

This past March, Mr. Bruce Bromage, Liquidmetal® Technologies’ Chief Operating Officer (COO), said, “We made excellent progress in 2017 toward establishing global manufacturing operations for our revolutionary technology. We made significant investments to commercialize our technologies and commission scalable manufacturing facilities. At the same time, we developed our markets through customer prototypes, and streamlined operations with reduced overhead costs…”

Liquidmetal Technologies, Inc. (LQMT), closed Thursday's trading session at $0.245, up 2.08%, on 442,053 volume with 89 trades. The average volume for the last 60 days is 1,058,379 and the stock's 52-week low/high is $0.1911/$0.44.

chart

Drone USA, Inc. (DRUS)

Stock News Now, Stock Daily Review, OTC Markets, InvestorsHub, 4-Traders, and Stockhouse reported on Drone USA, Inc. (DRUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Drone USA, Inc. is a developer, manufacturer, and distributor of low altitude drones and related technologies. The Company’s primary target markets include U.S. police, firemen, and the U.S. Government. Drone USA designs and builds high quality drones, training, insurance, replacement parts and anything a customer requires to ensure their missions are successful. All the Company’s products will be manufactured and assembled in the United States. Drone USA is headquartered in West Haven, Connecticut.

Drone USA services include Real Estate Photography for Advertisement; Utility Inspection; and Construction Inspection & Photo/Video Marketing. In addition, Services include Precision Agriculture; Search & Rescue Assistance; and Fire Hot Spot Location. All of the Company’s drones operate with closed encrypted software. This is for national security purposes. 

Founded in 1990, Howco Distributing Co. (Vancouver, Washington) is a subsidiary of Drone USA. Howco Distributing is the Company’s manufacturing supply chain segment. Howco Distributing is a premier supplier of spare and replacement parts to the United States Federal Government and commercial customers globally. Howco is an authorized provider for hundreds of manufacturers and original equipment manufacturers (OEMs).

Howco Distributing's services encompass bid solicitation, contract management, packaging and logistics for construction, transportation, mining and heavy equipment spare and replacement parts to customers worldwide using a wide variety of supply chain solutions. 

Drone USA  is working on three profitable growth strategies. These are Police & U.S. Government drone sales; increasing Howco Distributing’s product line and reach; and acquiring companies that expand Drone USA’s product and customer base.

Last month, Drone USA announced a reseller partnership with Thermaxx LLC. Thermaxx specializes in energy efficient insulation jackets. Thermaxx's solutions enable clients to save energy with user-friendly, removable insulation jackets when traditional stay-in-place insulation is not practical, particularly for mechanical systems, pipes, valves and heavy equipment.

This week, Drone USA announced subsidiary Howco Distributing was awarded a three year 1.7-million-dollar contract from the US Government's Defense Logistics Agency with an option to extend for two more years for trailer support components.

Drone USA, Inc. (DRUS), closed Thursday's trading session at $0.0175, down 11.17%, on 66,891,843 volume with 1,236 trades. The average volume for the last 60 days is 5,760,719 and the stock's 52-week low/high is $0.0043/$0.27.

chart

NuZee, Inc. (NUZE)

NetworkNewsWire, MarketWatch, Barchart, InvestorsHub, Zacks, OTC Markets, Capital Cube, Business Insider, and Stockopedia reported on NuZee, Inc. (NUZE), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

NuZee, Inc. focuses on building beverage brands that offer functional and nutritional benefits. The Company (d/b/a Coffee Blenders®) is the pioneer in functional coffee. It offers gourmet specialty grade coffee in convenient single serve cups using only natural ingredients with clinically supported nutraceuticals.

Formed in 2011, NuZee is based in Vista, California. The Company lists on the OTC Markets’ OTCQB.

NuZee’s customers include B2B (Business-to-Business) multi-store retail chains and wholesale distributors that deliver to chain and independent stores. Furthermore, NuZee sells its products to office and home delivery services that deliver coffee and water to homes and businesses locally.

The Company manufactures and sells its Drip Cup line of single serve, pour-over functional coffees. These include Lean Cup® (for weight loss), Think Cup® (for cognitive performance), Relax Cup® (for stress reduction), Active Cup® (for a pre-workout boost of energy), Nude Cup® (100 percent Arabica coffee with no function), and Matcha Cup tea. NuZee also manufactures and sells its Whole Bean coffee line.

NuZee has its ready-to-drink (RTD) gourmet, functional, cold brew coffee line. This product was initially available at independent retailers and convenience stores throughout Southern California. A national roll-out is continuing.

NuZee has undertaken the expansion of its existing production facility in Vista, California. This is to accommodate the growth of the Company’s Drip Cup line of functional gourmet coffee sold under the Coffee Blenders® brand name. NuZee adds two new Drip Cup co-packing machines and upgrades process automation as part of this expansion.

Recently, NuZee announced that it formed a new, wholly-owned subsidiary named NuZee KOREA LTD. NuZee KOREA will manage sales, marketing and associated activities for the Coffee Blenders’ line of Drip Cup functional coffees across Asia.

Sung-Man Kim will lead NuZee KOREA. He is a successful businessman and entrepreneur who has served as Chief Executive Officer (CEO) of Mystery Golf for 13 years.

Masa Higashida, NuZee's CEO, said, “NuZee KOREA will be our first manufacturing facility outside of the United States, and joins our Japan subsidiary, which we established in December of 2013 led by Katsuyoshi Eguchi, a successful businessman and entrepreneur who has served as CEO of Eguchi Holdings for 20 years [http://eguchi-hd.co.jp].  Together, these operations will allow us to better serve existing customers in China, Japan, and Korea, while providing the necessary resources to pursue new clients throughout Asia."

NuZee, Inc. (NUZE), closed Thursday's trading session at $0.65, even for the day. The average volume for the last 60 days is 133 and the stock's 52-week low/high is $0.25/$1.20.

chart

Terra Tech Corp. (TRTC)

Stock of the Week, Stockhouse, Epic Stock Picks, Street Register and Penny Stock Tweets reported on Terra Tech Corp. (TRTC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Terra Tech Corp. is a vertically integrated cannabis-focused agriculture company. It operates through numerous subsidiary businesses. These include Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Terra Tech’s commitment is to cultivate and provide the highest quality medical cannabis and other agricultural products. Listed on the OTCQX, Terra Tech is based in Irvine, California.

Terra Tech is integrating the best of the natural world with technology to create sustainable solutions for medical cannabis production, extraction and distribution, plant science research and development, food production, and Closed Environment Agriculture (CEA).

IVXX, Inc. is a wholly-owned subsidiary of Terra Tech. IVXX produces cannabis-extracted products for regulated medical cannabis dispensaries throughout California and medical and adult-use dispensaries in the State of Nevada.

Terra Tech has its wholly-owned subsidiary Edible Garden. It cultivates a premier brand of local and sustainably grown hydroponic produce. It sells via major grocery stores. In New Jersey, construction is taking place for a major new pack house to distribute salads and leafy greens for Edible Garden.

Terra Tech's MediFarm LLC subsidiaries focus on medical and adult-use cannabis cultivation. Additionally, MediFarm subsidiaries focus on permitting businesses throughout Nevada.

Blüm offers a broad selection of cannabis products. These include flowers, concentrates, and edibles through its Oakland, California and many Nevada locations.

Terra Tech’s capital expenditures for this calendar year will be directed toward the build out of its cultivation, extraction, and retail infrastructure in California, Nevada and New Jersey. In Oakland, Terra Tech is building a 13,000-square-foot cultivation facility. This facility will have the capacity to produce up to one metric ton, or 2,000 pounds, of cannabis per year.

Terra Tech has completed construction in Nevada of a new 30,000 square foot cannabis cultivation facility in Sparks and a 15,000 square foot cannabis extraction facility in Reno through agreements with NuLeaf. The Company is awaiting final State approval to start IVXX production at the Reno facility.

In June, Terra Tech announced that it began cultivation at its new Sparks facility, following approval from the State of Nevada. The team has successfully started cultivation of its first cannabis crop, planting the first seeds in early June. The Company expects to distribute and sell cannabis grown at the Sparks facility from its first harvest throughout Nevada by Q4 2018.

Terra Tech Corp. (TRTC), closed Thursday's trading session at $2.09, up 10.00%, on 2,557,313 volume with 2,261 trades. The average volume for the last 60 days is 670,795 and the stock's 52-week low/high is $0.175/$3.48.

chart

Algodon Wines & Luxury Development Group, Inc. (VINO)

OTC Markets Group, MarketWatch, Marketwired, Stock News Now, and Stockhouse reported on Algodon Wines & Luxury Development Group, Inc. (VINO), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Algodon Wines & Luxury Development Group, Inc. (Algodon Group) is a luxury lifestyle and real estate development brand with premium wines in Argentina. The Company identifies and develops vineyard operations, lifestyle properties, and other real estate assets and luxury brands in Argentina, and potentially more in other important areas of South America and internationally. Algodon Group is based in New York City. The Company also has offices in Buenos Aires and Mendoza.

Algodon’s current real estate developments include a Buenos Aires luxury boutique hotel, Algodon Mansion, in the city's most elegant residential neighborhood of Recoleta, and also the Mendoza wine resort, Algodon Wine Estates. This is a luxury vineyard estate in San Rafael, Argentina.

Algodon (using Algodon's icon wines as its ambassador) identifies and develops hotel, hospitality, and other lifestyle properties, and opportunities and brands that fit within its proprietary Algodon® brand.

Algodon Group announced in October of 2016 that it was awarded a gold medal in the Global Malbec Masters 2016 Wine Competition for its 2012 Black Label Malbec. The Global Malbec Masters (organized by The Drinks Business) is a prestigious series of blind tasting competitions, designed to reward the very best Malbecs around the world, ranging from the mountains of Mendoza and Chile's Maipo Valley to the châteaux of Cahors.

The 2012 Black Label Malbec represents the best selection from Algodon Fine Wines’ 1946 Malbec vines. The Black Label Malbec spends two years in new French oak after the microvinification method. The grapes undergo harvesting in late February, and are carefully selected directly in the vineyards.

Algodon Wine Estates is in San Rafael, Mendoza, in the foothills of the Sierra Pintadas. It produces a complete range of premium wines from land holdings that include noted parcels of pre-phylloxera vineyards dating back to the 1940s.

The Mendoza winery in the southernmost region of Argentina's wine capital is fed by the purest meltwater from the glacial Andes. Greater than 325 acres of vines go back as far as 1946 and produce first-rate fruit on sandy and clay loam.

Earlier in 2017, Algodon Wines & Luxury Development Group announced it partnered with The Eden Residence Club. This is to offer luxury services exclusively to Algodon Wine Estates homeowners and Algodon Group shareholders. The Eden Club is a global Private Members' Golf Club located in St Andrews, Scotland.

In May of this year, Algodon Wines & Luxury Development Group announced it partnered with Sherry-Lehmann Wine & Spirits to bring Algodon Fine Wines' portfolio of award-winning Malbec wines produced in the San Rafael, Mendoza wine region of Argentina to the U.S. This partnership represents Algodon Fine Wines' initial U.S. retailer. Sherry-Lehmann Wine & Spirits is a foremost wine and spirits merchant.

Algodon has completed the strategic acquisition of more land directly adjacent to the existing Algodon property. The new parcel measures 845 hectares or 2,088 acres. This more than doubles the size of Algodon Wine Estates.

Algodon Wines & Luxury Development Group, Inc. (VINO), closed Thursday's trading session at $0.95, up 35.71%, on 150 volume with 1 trade. The average volume for the last 60 days is 1,369 and the stock's 52-week low/high is $0.37/$2.50.

chart

Cantabio Pharmaceuticals, Inc. (CTBO)

Leeb’s Market Forecast, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, AwesomeStocks, HotStockProfits, ProfitableTrading, and Investors Alley reported earlier on Cantabio Pharmaceuticals, Inc. (CTBO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cantabio Pharmaceuticals, Inc. concentrates on bringing novel, first-in-class drug candidates into clinical trials and beyond. The OTCQB-listed Company does so through the discovery and development of inventive pharmacological chaperone and protein delivery based therapeutics, centering on protein systems implicated in neurodegenerative disorders. These include Alzheimer’s, Parkinson’s, and oxidative stress. Currently, Cantabio is engaging in advanced pre-clinical trials of its therapeutic candidates and is focused on developing these towards clinical trials.

Cantabio Pharmaceuticals, Inc. was established via the merger of Gardedam Therapeutics with Cantabio Pharmaceuticals in November of 2015. A preclinical stage biotechnology company, Cantabio Pharmaceuticals is based in Sunnyvale, California.

The Company is focusing on commercializing novel therapies and the Intellectual Property (IP) generated from its research and development (R&D) activities for Parkinson’s disease (PD), Alzheimer’s disease (AD), and other related neurodegenerative diseases. Its corporate strategy mixes a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach.

This particular approach is now identifying and developing small molecule pharmacological chaperones for clinical trials. Moreover, Cantabio is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins that display loss of function during disease conditions.

The Company has a new preclinical therapeutic program for Alzheimer’s disease that it is pursuing by way of its drug discovery partnership with NovAliX. This program is targeted at the development of small molecule chaperones, which stabilize the Abeta peptide, the aggregation of which is considered to be a critical element in the onset and progression of Alzheimer’s disease.

Cantabio Pharmaceuticals announced in July 2017 a publication lead authored by its Chief Executive Officer (CEO), Dr. Gergely Tóth, along with collaborators at the University of Cambridge, in the peer-reviewed journal ACS Chemical Neuroscience. The article is titled Detection and Characterization of Small Molecule Interactions with Fibrillar Protein Aggregates using Microscale Thermophoresis. It reported on a novel and general methodology for studying small molecule and protein fibril interactions. It demonstrated that one of the Company’s lead Tau targeting pharmacological chaperone molecules binds to Tau fibrils with high affinity.

Last month, Cantabio Pharmaceuticals announced a publication lead authored by CEO Dr. Gergely Tóth, along with collaborators at the Hungarian Academy of Sciences and Hungarian Brain Research Program, in the peer-reviewed journal Biochimica et Biophysica Acta - General Subjects.

The article, Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease, investigated a structure and biophysics-based mechanism by which the DJ-1 protein may lose its neuroprotective function because of high oxidative stress conditions that are present in brain cells of patients with neurodegenerative diseases such as AD and PD.

Cantabio Pharmaceuticals, Inc. (CTBO), closed Thursday's trading session at $0.0419, up 82.17%, on 121,253 volume with 13 trades. The average volume for the last 60 days is 69,336 and the stock's 52-week low/high is $0.01/$0.15.

chart

TechCare Corp. (TECR)

PennyStockTweets, Investors Hangout, InvestorsHub, OTC Markets, Investing.com, Barchart, Stockhouse, 4-Traders, GuruFocus, and Emerging Growth reported on TechCare Corp. (TECR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A technology enterprise, TechCare Corp. has a pioneering delivery platform that utilizes vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform employing vaporization of different natural, plant-based compounds, to enable a broad array of treatment solutions. TechCare is headquartered in New York, New York and the Company lists on the OTCQB.

TechCare has a strategic partnership agreement with HoMedics, one of the world's top brands in health and wellness products. HoMedics will manufacture, market, as well as distribute TechCare's Novokid products in the U.S., Canada, Brazil, Argentina, Colombia, and Costa Rica. The products will be co-branded as HoMedics products powered by TechCare.

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device.

Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, and also eggs. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid uses a proprietary vapor-based delivery platform.

Novokid utilizes a simple 10 minute dry treatment. This treatment necessitates no rinsing or washing. The treatment is quick, dry, and clean. In addition, it is easily administered at home or while mobile. Additionally, Novokid can be used as a maintenance and preventative treatment if used regularly.

In April 2017, TechCare announced that it filed a patent with the U.S. Patent and Trademark Office (USPTO) for its invention titled, "Treating an object with a gaseous compound in an airtight space". The Company was earlier issued patents in the United States and Europe for other components of its proprietary cold vapor technology platform. This includes one for treating head lice with gaseous compounds in an airtight space.

In late August of this year, TechCare and Natur Holdings B.V. announced the signing of a Memorandum of Understanding (MOU) to combine the operations of the two companies in an all-stock transaction to create a high-tech healthcare, wellness, healthy food, and beauty consumer products leader. Natur is Europe's first high-tech, Health Company transforming natural juices and snacks consumption.

Under the terms of the MOU, TechCare will acquire the assets, operations, and activities of Natur. This is in return for the issuance of TechCare common stock, representing 50 percent of the issued and outstanding common stock, on a fully diluted basis, immediately following their issuance.

TechCare Corp. (TECR), closed Thursday's trading session at $0.358, up 8.48%, on 713 volume with 4 trades. The average volume for the last 60 days is 4,753 and the stock's 52-week low/high is $0.02/$0.75.

chart

The Alkaline Water Company, Inc. (WTER)

Oakshire News Bulletin, StreetAuthority Financial, Penny Stock Rumble, InvestmentHouse, Investors Insights, Market FN, Wall Street Mover, SmallCapVoice, OTC Markets Group, MicroCap Gems, Investor Spec Sheet, and The Best Newsletters reported previously on The Alkaline Water Company, Inc. (WTER), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

The Alkaline Water Company, Inc. has developed an inventive, state-of-the-art, proprietary electrolysis beverage process, which produces healthy alkaline water. This water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1 gallon sizes under the trade name Alkaline88®. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes.

The Alkaline Water Company has its corporate office in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB. Alkaline88® ranks among the fastest-growing premium bottled water brands, with revenue increasing over 2,100 percent since Fiscal Year (FY) 2013.

The design of Alkaline88 is to encourage daily consumption of Alkaline Water via a consumer-oriented bulk delivery system targeted at removing expensive small bottles from the distribution supply chain. The production of Alkaline88 is at an 8.8 pH, intended to achieve optimal body balance. 

Alkaline88 contains trace Himalayan minerals. The Company incorporated 84 beneficial trace Himalayan minerals to make Alkaline88 especially unique to other pH waters.

The Alkaline Water Company employs an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals. The ECA process utilizes specialized electronic cells coated with an assortment of rare earth minerals to produce scientifically engineered water.   

The Alkaline Water Company has established key co-packing facilities across the United States to support its national expansion campaign. The Company currently has six co-packers across the nation that have up to a combined $72 million of production capabilities. These are situated within 600 miles of 95 percent of the U.S. population.

In less than five years, Alkaline88® has expanded to more than half of the top 75 food retailers and wholesalers in the United States. The Alkaline88® brand is presently available in greater than 32,000 retail locations across the nation. The expectation is that distribution will surpass 40,000 locations by the end of FY 2018.

In FY 2017, The Alkaline Water Company secured placement for Alkaline88® with VMC, Harris Teeter, Festival Foods, 7-Eleven stores (in Southern California), Fresh Thyme Farmers Market, Food Depot Supermarkets, Hornbacher's, Super One Foods, Food Lion, Winn-Dixie, BI-LO, Dierbergs Markets, Sendik's Food Market, and Ingles Markets.

This month, The Alkaline Water Company announced that Bodega Latina Corporation, dba El Super, is now selling Alkaline88® water in the 3-liter and 500ml sizes. The Company’s placement into El Super (number 64 on the Supermarket News list of 2017 Top 75 Retailers and Wholesalers) makes Alkaline88® available in more than 32,000 retail locales across the nation.

The Alkaline Water Company, Inc. (WTER), closed Thursday's trading session at $1.845, up 1.37%, on 30,876 volume with 39 trades. The average volume for the last 60 days is 48,629 and the stock's 52-week low/high is $0.80/$2.25.

chart

Sunset Island Group, Inc. (SIGO)

PennyStockSpy, OTCPicks, MicrocapVoice, and 007 Stock Chat reported previously on Sunset Island Group, Inc. (SIGO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business arena. The Company centers on providing a licensed manufacturing facility to clients for producing products, such as oils and edibles. Sunset Island Group lists on the OTC Markets Group’s OTCQB. The Company is based in San Clemente, California.

Fundamentally, Sunset Island Group’s vision is to establish a fully integrated company that provides turnkey solutions to the medical cannabis industry. Its principal focus is on providing a licensed facility where companies can manufacture and produce their products. Also, it will provide distribution for companies by way of an established network of dispensaries.

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company’s space underwent inspection in April of this year as part of the permitting process. Sunset Island filed for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis annually.

Sunset Island announced in February 2017 that it began development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.

These products will at first sell via the Company’s website. Sunset Island expects to expand by selling through Amazon and other retailers. It will continue to develop products that will address the demands in the international dietary supplements market, targeted to soon reach in excess of $200 billion.

The product will be developed by a trained French Chef with over 20 years of experience in Product Development and Food Production. In addition, this Chef has developed products from their concept stage to national distribution that have produced more than $100 million in sales.

According to industry research firm GreenWave Advisors, the consumption of marijuana for medical and recreational use could increase to a $35 billion market by the year 2020. GreenWave Advisors tracks retail sales in the four states and the District of Columbia (DC), which have already legalized it.

In late September, Sunset Island Group announced that it started a retrofit to its present grow space, which will substantially increase the amount of cannabis product produced with each harvest.

T.J. Magallanes, Chief Executive Officer, stated, "The obvious solution to increasing the number of pounds of cannabis produced each year is more space, but effective utilization of the space that you already have is also important. With that in mind, effective immediately we are retrofitting our original 10,000 square feet of grow space at a cost of approximately $75,000. The return on this investment will be considerable and we predict we will be able to increase our yield by 50 percent.”

Moreover, the Company announced this month that it has started an aggressive expansion of its cannabis product line.

Sunset Island Group, Inc. (SIGO), closed Thursday's trading session at $0.651, up 2.52%, on 9,551 volume with 18 trades. The average volume for the last 60 days is 19,448 and the stock's 52-week low/high is $0.10/$3.30.

chart

The QualityStocks Company Corner

GreenBox POS, LLC (OTCQB: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.25, even for the day, on 1,000 volume with 1 trade. The average volume for the last 60 days is 16,574 and the stock's 52-week low/high is $0.017/$0.56.

Recent News

chart

GTX Corp. (OTC: GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp. (GTXO).

GTX Corp. (OTC: GTXO) has released two new GPS products to safeguard the location of children. They are the patented SmartSole® in size small and the Invisabelt for toddlers and kids (http://nnw.fm/x5oHa). GTXO offers tracking devices and services in a global market, providing smart and wearable GPS tracking products for people and tracking technologies for high value assets through its IoT monitoring platform. Also today, NetworkNewsWire released a report on the company detailing how GTXO is “One to Watch.”

GTX Corp. (OTC: GTXO) designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://nnw.fm/mrcV2), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp. (GTXO), closed the day's trading session at $0.002, up 5.26%, on 2,807,789 volume with 25 trades. The average volume for the last 60 days is 5,391,065 and the stock's 52-week low/high is $0.0011/$0.0089.

Recent News

chart

Zenergy Brands, Inc. (OTC: ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY), through its platform that combines energy services and smart controls, is poised to capitalize on the world’s growing desire to become more energy-efficient. To view the full article, visit: http://nnw.fm/762Sy.

Zenergy Brands, Inc. (OTC: ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0019, up 18.75%, on 48,677,641 volume with 125 trades. The average volume for the last 60 days is 8,901,441 and the stock's 52-week low/high is $0.0014/$0.032.

Recent News

chart

Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) this morning, alongside a long list of licensed producers, announced supply agreements with the Alberta Gaming, Liquor & Cannabis Commission to supply the province with high-quality cannabis products in anticipation of the mid-October kick-off date for recreational sales in Canada.

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed the day's trading session at $1.1014, up 1.05%, on 113,689 volume with 176 trades. The average volume for the last 60 days is 280,225 and the stock's 52-week low/high is $0.20/$3.8799.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) has developed an innovative system called QuadSight™ that uses two pairs of stereoscopic infrared and daylight cameras that surpass a driver’s ability to see, regardless of weather or lighting conditions. To view the full article, visit: http://nnw.fm/93k6T.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $3.29, up 0.30%, on 29,242 volume with 148 trades. The average volume for the last 60 days is 55,115 and the stock's 52-week low/high is $2.44/$10.45.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Biosciences Inc. (CSE:LXX) (LXX.CN) (CNSX:LXX) (OTCQX:LXRP), which originally developed its DehydraTECH™ platform to increase the bioavailability of cannabinoids.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.10, up 5.00%, on 99,782 volume with 243 trades. The average volume for the last 60 days is 268,531 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) (“ABcann”) is pleased to announce that it has completed an agreement with the Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to supply the province with high-quality cannabis products.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” ABcann Global CEO Barry Fishman said.

ABcann Global owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

ABcann has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by ABcann’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting ABcann’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

ABcann’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with ABcann’s philosophy of quality and innovation.

ABcann’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, ABcann also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

ABcann Global (ABCCF), closed the day's trading session at $1.02, up 0.99%, on 121,093 volume with 154 trades. The average volume for the last 60 days is 243,462 and the stock's 52-week low/high is $0.65/$3.2929.

Recent News

chart

Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, is pleased to announce the brand name of its innovative MSN-2 medical device.

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.80, even for the day, on 6,751 volume with 18 trades. The average volume for the last 60 days is 13,008 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Texas-based Sharing Services (OTC: SHRV) recently applauded its team of home-based independent sales representatives for executing a go-to-market selling technique, which focuses on the end user when delivering a product or service. To view the full article, visit: http://nnw.fm/M9ujB.

Sharing Services, Inc. (OTC: SHRV) headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.32, even for the day, on 16,420 volume with 7 trades. The average volume for the last 60 days is 35,369 and the stock's 52-week low/high is $0.125/$1.07.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (SNOVF).

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) (the "Company" or "Koios") is pleased to announce it has launched direct shipping to Canada for its line of nootropic, brain-enhancing products. Koios has now put in place the logistics for direct shipping to Canada through their online sales portal at https://www.mentaltitan.com/shop/.

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (SNOVF), closed the day's trading session at $0.1693, off by 3.04%, on 36,252 volume with 23 trades. The average volume for the last 60 days is 56,730 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

It’s not often that you get a winning combination from a mineral exploration company like the one put together by Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF). The junior explorer, based in Vancouver, Canada, has assembled a portfolio of claims that compose properties containing lithium, cobalt, gold and other valuable elements and minerals.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.1242, even for the day. The average volume for the last 60 days is 2,090 and the stock's 52-week low/high is $0.01/$0.165.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. Also today, CannabisNewsWire released a report on the company detailing how PRVCF is working on the advancement of its Sol-gel drug delivery research program. To view the full article, visit: http://cnw.fm/G68qn.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.0503, even for the day, on 25,000 volume with 5 trades. The average volume for the last 60 days is 19,637 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.